E. S. Ozyurek Et Al. , "Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)," JOURNAL OF OVARIAN RESEARCH , vol.10, 2017
Ozyurek, E. S. Et Al. 2017. Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study). JOURNAL OF OVARIAN RESEARCH , vol.10 .
Ozyurek, E. S., Yoldemir, T., & Artar, G., (2017). Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study). JOURNAL OF OVARIAN RESEARCH , vol.10.
Ozyurek, Eser, AHMET TEVFİK YOLDEMİR, And Gokhan Artar. "Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)," JOURNAL OF OVARIAN RESEARCH , vol.10, 2017
Ozyurek, Eser S. Et Al. "Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)." JOURNAL OF OVARIAN RESEARCH , vol.10, 2017
Ozyurek, E. S. Yoldemir, T. And Artar, G. (2017) . "Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)." JOURNAL OF OVARIAN RESEARCH , vol.10.
@article{article, author={Eser Sefik Ozyurek Et Al. }, title={Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)}, journal={JOURNAL OF OVARIAN RESEARCH}, year=2017}